Fortrea Holdings Inc. - Common Stock · Transaction Jun 23, 2025 · Filed Jul 24, 2025 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · FTRE
+5.89% · +$1.06 · Vol 1.9M
After hours · updated 16:00:15 ET
Fortrea Holdings Inc
Life Sciences Tools & Services
$19.05
Veridion Score
BETAHIGH CONF · 6/6 factorsStale score · Tue Aug 4 · completed session · 22h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET · FTRE
MethodologyFTRE
Fortrea Holdings Inc
Stale score · Tue Aug 4 · completed session · 22h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
67/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Stale score · Tue Aug 4 · completed session · 22h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is FTRE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Fortrea Holdings Inc
SERVICES-MEDICAL LABORATORIESListed since
2023
Employees
14K
Country
US
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$18.10
Day high
$19.71
Day low
$18.10
Previous close
$17.99
52W high
$20.70
-7.97% from high
52W low
$6.39
88% of range
Market cap
$1.7B
EPS
$-4.7000
Beta
1.09
Shares out
95.1M
Volume
1.9M
1.17× rel vol
Avg volume
1.6M
VWAP
$19.13
Price history computed in-house
1W
-6.62%
1M
+6.72%
3M
+22.35%
1Y
+190.40%
YTD
+10.43%
SMA 50 $17.25 · above
SMA 200 $13.78 · above
52W position 88%
FTRE overview
Veridion Score
67
6 of 6 factors measured
Congress receipts
1
James French Hill · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in FTRE
Official filing ↗
Federal contracts
FTRE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FTRE in this window.
Lobbying spend
FTRE lobbying filings, year to date.
Registered lobbying filings matched to Fortrea Holdings Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FTRE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for FTRE.
Options
Sovereign unlock shows live options positioning for FTRE.